{"id":295345,"date":"2018-11-26T08:56:02","date_gmt":"2018-11-26T08:56:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=295345"},"modified":"2018-11-26T08:56:02","modified_gmt":"2018-11-26T08:56:02","slug":"biologics-and-biosimilars-global-market-industry-analysis-growth-trends-opportunity-and-forecast-2018-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/biologics-and-biosimilars-global-market-industry-analysis-growth-trends-opportunity-and-forecast-2018-to-2023_295345.html","title":{"rendered":"Biologics and Biosimilars Global Market, Industry Analysis, Growth Trends, Opportunity and Forecast 2018 to 2023"},"content":{"rendered":"
\n
“Biologics and Biosimilars Market”<\/div>\n<\/div>\n
WiseGuyReports.com adds \u201cBiologics and Biosimilars Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023\u201d<\/div>\n

Summary<\/strong><\/p>\n

WiseGuyReports.com adds “Biologics and Biosimilars Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023”<\/strong> reports to its database.<\/p>\n

This report provides in depth study of “Biologics and Biosimilars<\/strong> Market<\/strong>” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Biologics and Biosimilars <\/strong>Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.<\/p>\n

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product’s patent expires. <\/p>\n

Global Biologics and Biosimilars<\/strong><\/a> market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including 
Roche 
Amgen 
AbbVie 
Sanofi-Aventis 
Johnson & Johnson 
Pfizer 
Novo Nordisk 
Eli Lilly 
Novartis 
Merck 
3sbio 
Changchun High Tech 
CP Guojian 
Biotech 
Gelgen 
Innovent 
Dong Bao 
Ganlee 
United Laboratories<\/strong><\/p>\n

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. 
Market Segment as follows: 
By Region \/ Countries 
<\/strong>North America (U.S., Canada, Mexico) 
Europe (Germany, U.K., France, Italy, Russia, Spain etc) 
South America (Brazil, Argentina etc) 
Middle East & Africa (Saudi Arabia, South Africa etc) <\/p>\n

By Type 
<\/strong>Antibody 
Hormone 
Growth Factors 
Others <\/p>\n

By End-User \/ Application 
<\/strong>Tumor 
Diabetes 
Cardiovascular 
Hemophilia 
Others <\/p>\n

Request a Sample Report @ <\/strong>https:\/\/www.wiseguyreports.com\/sample-request\/2661962-2015-2023-world-biologics-and-biosimilars-market-research-report-by-product<\/strong><\/a><\/p>\n

Major Key Points in Table of Content<\/strong><\/p>\n

1 Market Definition 
<\/strong>1.1 Market Segment Overview 
1.2 by Type 
1.3 by End-Use \/ Application <\/p>\n

2 Global Market by Vendors 
<\/strong>2.1 Market Share 
2.2 Vendor Profile 
2.3 Dynamic of Vendors <\/p>\n

3 Global Market by Type 
<\/strong>3.1 Market Share 
3.2 Introduction of End-Use by Different Products <\/p>\n

4 Global Market by End-Use \/ Application 
<\/strong>4.1 Market Share 
4.2 Overview of Consumption Characteristics 
4.2.1 Preference Driven 
4.2.2 Substitutability 
4.2.3 Influence by Strategy 
4.2.4 Professional Needs <\/p>\n

5 Global Market by Regions 
<\/strong>5.1 Market Share 
5.2 Regional Market Growth 
5.2.1 North America 
5.2.2 Europe 
5.2.3 Asia-Pacific 
5.2.4 South America 
5.2.5 Middle East & Africa <\/p>\n

….<\/strong><\/p>\n

12 Key Manufacturers 
12.1 Roche 
<\/strong>12.1.2 Company Overview 
12.1.2 Product and End-User \/ Application 
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.2 Amgen 
<\/strong>12.2.1 Company Overview 
12.2.2 Product and End-User \/ Application 
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.3 AbbVie 
<\/strong>12.3.1 Company Overview 
12.3.2 Product and End-User \/ Application 
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.4 Sanofi-Aventis 
<\/strong>12.4.1 Company Overview 
12.4.2 Product and End-User \/ Application 
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.5 Johnson & Johnson 
<\/strong>12.5.1 Company Overview 
12.5.2 Product and End-User \/ Application 
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.6 Pfizer 
<\/strong>12.12.1 Company Overview 
12.12.2 Product and End-User \/ Application 
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.7 Novo Nordisk 
<\/strong>12.7.1 Company Overview 
12.7.2 Product and End-User \/ Application 
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.8 Eli Lilly 
<\/strong>12.8.1 Company Overview 
12.8.2 Product and End-User \/ Application 
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.9 Novartis 
<\/strong>12.9.1 Company Overview 
12.9.2 Product and End-User \/ Application 
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.10 Merck 
<\/strong>12.10.1 Company Overview 
12.10.2 Product and End-User \/ Application 
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.11 3sbio 
12.12 Changchun High Tech 
12.13 CP Guojian 
12.14 Biotech 
12.15 Gelgen 
12.16 Innovent 
12.17 Dong Bao 
12.18 Ganlee 
12.19 United Laboratories <\/strong><\/p>\n

At any Query @ <\/strong>https:\/\/www.wiseguyreports.com\/enquiry\/2661962-2015-2023-world-biologics-and-biosimilars-market-research-report-by-product<\/strong><\/a><\/p>\n

Continued….<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Biologics and Biosimilars Market” WiseGuyReports.com adds \u201cBiologics and Biosimilars Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023\u201d Summary WiseGuyReports.com adds “Biologics and Biosimilars Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-295345","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/295345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=295345"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/295345\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=295345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=295345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=295345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}